Jerusalem, 5 October, 2025 (TPS-IL) — Israeli company MedHub-AI has won national reimbursement approval in Japan for its AutocathFFR system, an AI-based tool that checks blood flow in the heart during angiography.
AutocathFFR works without wires or special drugs, giving fast, accurate results and making procedures simpler for doctors. MedHub-AI CEO Or Bruch-El said the approval shows the system’s value and will help expand its use in hospitals across Japan through the company’s partnership with Terumo Corporation.